We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.3B
AUM Growth
-$265M
Cap. Flow
-$917M
Cap. Flow %
-3.93%
Top 10 Hldgs %
47.97%
Holding
197
New
23
Increased
32
Reduced
40
Closed
30

Sector Composition

Rank Sector Weight
1 Healthcare 29.33%
2 Technology 12.47%
3 Financials 9.64%
4 Industrials 5.44%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
26
Alphabet (Google) Class C
GOOG
$4.36T
$330M 1.41%
1,796,540
-1,541,410
-46% -$262M
BSX icon
27
Boston Scientific
BSX
$71.4B
$316M 1.36%
4,109,157
-487,500
-11% -$35.7M
ADI icon
28
Analog Devices
ADI
$184B
$293M 1.26%
1,284,800
-253,190
-16% -$54M
ABNB icon
29
Airbnb
ABNB
$90B
$258M 1.11%
1,701,000
+92,780
+6% +$14.2M
AGIO icon
30
Agios Pharmaceuticals
AGIO
$1.91B
$244M 1.05%
5,654,502
+63,900
+1% +$2.31M
V icon
31
Visa
V
$692B
$216M 0.93%
821,886
+141,036
+21% +$38.7M
YMM icon
32
Full Truck Alliance
YMM
$9.89B
$208M 0.89%
25,850,303
-434,756
-2% -$3.7M
MA icon
33
Mastercard
MA
$505B
$204M 0.88%
462,771
-50,390
-10% -$23M
PTGX icon
34
Protagonist Therapeutics
PTGX
$9.4B
$202M 0.87%
5,840,773
+101,800
+2% +$2.98M
HCP
35
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$199M 0.85%
+5,905,000
New +$184M
HWM icon
36
Howmet Aerospace
HWM
$116B
$197M 0.85%
2,541,839
-868,920
-25% -$65.8M
SHW icon
37
Sherwin-Williams
SHW
$88.2B
$193M 0.83%
647,550
-106,280
-14% -$32.9M
AZN icon
38
AstraZeneca
AZN
$250B
$188M 0.81%
1,204,859
+475,000
+65% +$71.5M
BEAM icon
39
Beam Therapeutics
BEAM
$2.81B
$185M 0.8%
7,913,123
+3,401,370
+75% +$83.5M
LNTH icon
40
Lantheus
LNTH
$6.6B
$183M 0.79%
2,279,227
+796,000
+54% +$58.4M
MRNA icon
41
PUT
Moderna
MRNA
$21.5B
$154M 0.66%
+1,300,000
New +$165M
SRCL
42
DELISTED
Stericycle Inc
SRCL
$149M 0.64%
+2,560,000
New +$131M
CNC icon
43
Centene
CNC
$31.7B
$144M 0.62%
2,168,175
-439,700
-17% -$32M
MASI
44
DELISTED
Masimo
MASI
$141M 0.61%
1,119,563
-370,000
-25% -$48.7M
AMED
45
DELISTED
Amedisys
AMED
$120M 0.52%
1,308,500
+300,200
+30% +$27.9M
EDU icon
46
New Oriental
EDU
$9.04B
$114M 0.49%
1,469,590
+854,590
+139% +$69.6M
THC icon
47
Tenet Healthcare
THC
$20.7B
$91.5M 0.39%
687,442
+50,000
+8% +$6.02M
ANSS
48
DELISTED
Ansys
ANSS
$82M 0.35%
255,000
LBPH
49
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$79.5M 0.34%
2,940,500
BHVN icon
50
Biohaven
BHVN
$2.17B
$78M 0.33%
2,248,000
+1,449,000
+181% +$57.3M

Similar funds

Farallon Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Farallon Capital Management held 197 positions worth $23.3B, down 1.1% from $23.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management withdrew a net $917M in Q2 2024, closing 30 positions and reducing 40 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $924M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Walt Disney worth $356M.

  • Farallon Capital Management's largest Q2 2024 buy was Walt Disney: 3,582,168 shares worth $356M.
  • Farallon Capital Management added most to Aon in Q2 2024, an estimated $368M increase.
  • Farallon Capital Management's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $262M.
  • Farallon Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $924M.
  • Farallon Capital Management's ten largest holdings make up 48% of its $23.3B portfolio in Q2 2024.
  • Farallon Capital Management opened 23 new positions and closed 30 in Q2 2024.
  • Farallon Capital Management's portfolio value fell 1.1% quarter-over-quarter to $23.3B.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.